Back to Search
Start Over
Levena Biopharma announces clinical data for A166 in breast cancer
- Source :
- The Fly. May 3, 2022
- Publication Year :
- 2022
-
Abstract
- Sorrento Therapeutics announced that its license and development partner, Sichuan Kelun-Biotech Biopharmaceutical, presented at this year's Chinese Society of Clinical Oncology Guideline Conference Phase 1 data for its anti-HER2-ADC, A166. [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.702358753